Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17633490 | 1.00 | CYP1A2 (0.31) | CYP1A2 | |
| SCHEMBL17629236 | 1.00 | CYP1A2 (0.31) | CYP1A2 | |
| SCHEMBL19451853 | 0.88 | — | — | |
| SCHEMBL29414515 | 0.80 | — | — | |
| SCHEMBL17859726 | 0.79 | — | — | |
| SCHEMBL15663254 | 0.77 | EPHX1 (0.44) | CYP1A2 | |
| SCHEMBL140451 | 0.74 | — | — | |
| SCHEMBL2349153 | 0.74 | — | — | |
| SCHEMBL2348175 | 0.74 | — | — | |
| SCHEMBL111930 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3197987-B1 | USE OF ISOMERICALLY PURE OR HIGHLY ISOMERICALLY ENRICHED CIS- OR TRANS- (2-ISOBUTYL-4-METHYL-TETRAHYDROPYRAN-4-YL) ACETATE | BASF SE (DE) | 2019-01-23 | — | — | EP | claimed |
| EP-3197987-A1 | USE OF ISOMERICALLY PURE OR HIGHLY ISOMER-ENRICHED CIS- OR TRANS-(2-ISOBUTYL-4-METHYL-TETRAHYDROPYRAN-4-YL)ACETATE | BASF SE (DE) | 2017-08-02 | — | — | EP | claimed |
| WO-2016046360-A1 | USE OF ISOMERICALLY PURE OR HIGHLY ISOMER-ENRICHED CIS- OR TRANS-(2-ISOBUTYL-4-METHYL-TETRAHYDROPYRAN-4-YL)ACETATE | BASF SE (DE) | 2016-03-31 | — | — | WO | claimed |
| EP-3873658-A1 | METHOD FOR PRODUCING MICROPARTICLES WHICH ARE CHARGED WITH AN ACTIVE MATERIAL | BASF SE (DE) | 2021-09-08 | — | — | EP | disclosed |
| CN-113164897-A | Method for preparing microparticles filled with active material | 巴斯夫欧洲公司 | 2021-07-23 | — | — | CN | disclosed |
| EP-3265451-B1 | METHOD FOR THE PREPARATION OF TETRAHYDROPYRANYL ESTERS | BASF SE (DE) | 2020-08-26 | — | — | EP | disclosed |
| EP-3483151-A1 | TETRAHYDROPYRANYL ESTERS AS ODORANTS | BASF SE (DE) | 2019-05-15 | — | — | EP | disclosed |
| EP-3197987-B1 | USE OF ISOMERICALLY PURE OR HIGHLY ISOMERICALLY ENRICHED CIS- OR TRANS- (2-ISOBUTYL-4-METHYL-TETRAHYDROPYRAN-4-YL) ACETATE | BASF SE (DE) | 2019-01-23 | — | — | EP | disclosed |
| US-10160931-B2 | Use of isomerically pure or highly isomer-enriched cis- or trans-(2-isobutyl-4-methyl-tetrahydropyran-4-yl)acetate | BASF SE (DE) | 2018-12-25 | — | — | US | disclosed |
| US-10160931-B2 | Use of isomerically pure or highly isomer-enriched cis- or trans-(2-isobutyl-4-methyl-tetrahydropyran-4-yl)acetate | BASF SE (DE) | 2018-12-25 | — | — | US | disclosed |
| EP-3197987-A1 | USE OF ISOMERICALLY PURE OR HIGHLY ISOMER-ENRICHED CIS- OR TRANS-(2-ISOBUTYL-4-METHYL-TETRAHYDROPYRAN-4-YL)ACETATE | BASF SE (DE) | 2017-08-02 | — | — | EP | disclosed |
| EP-3197987-A1 | USE OF ISOMERICALLY PURE OR HIGHLY ISOMER-ENRICHED CIS- OR TRANS-(2-ISOBUTYL-4-METHYL-TETRAHYDROPYRAN-4-YL)ACETATE | BASF SE (DE) | 2017-08-02 | — | — | EP | disclosed |
| CN-106715408-A | Use of isomerically pure or highly isomer-enriched cis- or trans-(2-isobutyl-4-methyl-tetrahydropyran-4-yl)acetate | 巴斯夫欧洲公司 | 2017-05-24 | — | — | CN | disclosed |
| CN-106715408-A | Use of isomerically pure or highly isomer-enriched cis- or trans-(2-isobutyl-4-methyl-tetrahydropyran-4-yl)acetate | 巴斯夫欧洲公司 | 2017-05-24 | — | — | CN | disclosed |
| WO-2016046360-A1 | USE OF ISOMERICALLY PURE OR HIGHLY ISOMER-ENRICHED CIS- OR TRANS-(2-ISOBUTYL-4-METHYL-TETRAHYDROPYRAN-4-YL)ACETATE | BASF SE (DE) | 2016-03-31 | — | — | WO | disclosed |
| WO-2016046360-A1 | USE OF ISOMERICALLY PURE OR HIGHLY ISOMER-ENRICHED CIS- OR TRANS-(2-ISOBUTYL-4-METHYL-TETRAHYDROPYRAN-4-YL)ACETATE | BASF SE (DE) | 2016-03-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10160931-B2 | Use of isomerically pure or highly isomer-enriched cis- or trans-(2-isobutyl-4-methyl-tetrahydropyran-4-yl)acetate | HPD, ACMSD, TES | CYP1A2 339/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.